July 24 (Reuters) - Trans1 Inc. filed with U.S. regulators on Tuesday to raise up to $80.5 million in an initial public offering of common stock.
The medical device company told the U.S. Securities and Exchange Commission in a filing that Lehman Brothers, Cowen & Co., Piper Jaffray and Leerink Swann & Co. were underwriting the IPO.
Trans1 said it applied for a Nasdaq listing under the symbol “TSON.”
The filing did not reveal how many shares the company planned to sell or their expected price. (Reporting by Aniruddha Basu in Bangalore)